Listed

Imunon, Inc.

IMNNNasdaqCIK 749647HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$2.8m, Q2 FY2026
Net income−$2.8m, Q2 FY2026
Imunon, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$k1,981Research and development, Q3 FY2023, three months to 2023-09-30$2.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0001493152-24-043931.Report this figure3,553Research and development, Q4 FY2023, three months to 2023-12-31$3.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-02-27, accession 0001493152-25-008460. Derived: 12-month figure less the 9-month figure.Report this figure3,294Research and development, Q1 FY2024, three months to 2024-03-31$3.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0001641172-25-009572.Report this figure2,820Research and development, Q2 FY2024, three months to 2024-06-30$2.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-05, accession 0001493152-25-011598.Report this figure3,293Research and development, Q3 FY2024, three months to 2024-09-30$3.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001493152-25-022120.Report this figure2,233Research and development, Q4 FY2024, three months to 2024-12-31$2.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001493152-26-013850. Derived: 12-month figure less the 9-month figure.Report this figure2,165Research and development, Q1 FY2025, three months to 2025-03-31$2.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001493152-26-022416.Report this figure1,227Research and development, Q2 FY2025, three months to 2025-06-30$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure1,899Research and development, Q3 FY2025, three months to 2025-09-30$1.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-13, accession 0001493152-25-022120.Report this figure2,489Research and development, Q4 FY2025, three months to 2025-12-31$2.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-31, accession 0001493152-26-013850. Derived: 12-month figure less the 9-month figure.Report this figure2,337Research and development, Q1 FY2026, three months to 2026-03-31$2.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-12, accession 0001493152-26-022416.Report this figure1,465Research and development, Q2 FY2026, three months to 2026-06-30$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure
Operating income$k(3,904)Operating income, Q3 FY2023, three months to 2023-09-30−$3.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0001493152-24-043931.Report this figure(5,968)Operating income, Q4 FY2023, three months to 2023-12-31−$6.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-27, accession 0001493152-25-008460. Derived: 12-month figure less the 9-month figure.Report this figure(5,011)Operating income, Q1 FY2024, three months to 2024-03-31−$5.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0001641172-25-009572.Report this figure(5,013)Operating income, Q2 FY2024, three months to 2024-06-30−$5.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-05, accession 0001493152-25-011598.Report this figure(4,961)Operating income, Q3 FY2024, three months to 2024-09-30−$5.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022120.Report this figure(4,146)Operating income, Q4 FY2024, three months to 2024-12-31−$4.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-013850. Derived: 12-month figure less the 9-month figure.Report this figure(4,145)Operating income, Q1 FY2025, three months to 2025-03-31−$4.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001493152-26-022416.Report this figure(2,768)Operating income, Q2 FY2025, three months to 2025-06-30−$2.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure(3,476)Operating income, Q3 FY2025, three months to 2025-09-30−$3.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022120.Report this figure(4,262)Operating income, Q4 FY2025, three months to 2025-12-31−$4.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-013850. Derived: 12-month figure less the 9-month figure.Report this figure(4,307)Operating income, Q1 FY2026, three months to 2026-03-31−$4.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0001493152-26-022416.Report this figure(2,792)Operating income, Q2 FY2026, three months to 2026-06-30−$2.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure
Interest expense$k0.0Interest expense, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-14, accession 0001493152-23-040803. Derived: 9-month figure less the 6-month figure.Report this figure0.0Interest expense, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-28, accession 0001493152-24-011616. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported77.3Interest expense, Q2 FY2026, three months to 2026-06-30$77.3k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure
Net income$k(3,477)Net income, Q3 FY2023, three months to 2023-09-30−$3.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0001493152-24-043931.Report this figure(4,888)Net income, Q4 FY2023, three months to 2023-12-31−$4.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-27, accession 0001493152-25-008460. Derived: 12-month figure less the 9-month figure.Report this figure(4,930)Net income, Q1 FY2024, three months to 2024-03-31−$4.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-12, accession 0001641172-25-009572.Report this figure(4,788)Net income, Q2 FY2024, three months to 2024-06-30−$4.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-05, accession 0001493152-25-011598.Report this figure(4,845)Net income, Q3 FY2024, three months to 2024-09-30−$4.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022120.Report this figure(4,057)Net income, Q4 FY2024, three months to 2024-12-31−$4.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-013850. Derived: 12-month figure less the 9-month figure.Report this figure(4,102)Net income, Q1 FY2025, three months to 2025-03-31−$4.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001493152-26-022416.Report this figure(2,741)Net income, Q2 FY2025, three months to 2025-06-30−$2.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure(3,429)Net income, Q3 FY2025, three months to 2025-09-30−$3.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001493152-25-022120.Report this figure(4,223)Net income, Q4 FY2025, three months to 2025-12-31−$4.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-31, accession 0001493152-26-013850. Derived: 12-month figure less the 9-month figure.Report this figure(4,249)Net income, Q1 FY2026, three months to 2026-03-31−$4.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0001493152-26-022416.Report this figure(2,814)Net income, Q2 FY2026, three months to 2026-06-30−$2.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure
Diluted EPS$ per share(0.37)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0001493152-24-043931.Report this figurenot reported(0.52)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-12, accession 0001641172-25-009572.Report this figure(7.64)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$7.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-05, accession 0001493152-25-011598.Report this figure(3.76)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$3.76 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001493152-25-022120.Report this figurenot reported(3.15)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$3.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001493152-26-022416.Report this figure(2.15)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$2.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure(1.16)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001493152-25-022120.Report this figurenot reported(0.84)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.84 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0001493152-26-022416.Report this figure(0.54)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure
Basic EPS$ per share(0.37)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0001493152-24-043931.Report this figurenot reported(0.52)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0001641172-25-009572.Report this figure(7.64)Basic EPS, Q2 FY2024, three months to 2024-06-30−$7.64 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-05, accession 0001493152-25-011598.Report this figure(3.76)Basic EPS, Q3 FY2024, three months to 2024-09-30−$3.76 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001493152-25-022120.Report this figurenot reported(3.15)Basic EPS, Q1 FY2025, three months to 2025-03-31−$3.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001493152-26-022416.Report this figure(2.15)Basic EPS, Q2 FY2025, three months to 2025-06-30−$2.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure(1.16)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001493152-25-022120.Report this figurenot reported(0.84)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.84 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0001493152-26-022416.Report this figure(0.54)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.54 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure

Balance sheet

Cash and equivalents$6.9m, Q2 FY2026
Shareholders' equity$4.2m, Q2 FY2026
Imunon, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m12.9Cash and equivalents, Q3 FY2023, at 2023-09-30$12.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-14, accession 0001493152-23-040803.Report this figure5.8Cash and equivalents, FY2023, at 2023-12-31$5.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-27, accession 0001493152-25-008460.Report this figure2.3Cash and equivalents, Q1 FY2024, at 2024-03-31$2.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-13, accession 0001493152-24-018795.Report this figure5.3Cash and equivalents, Q2 FY2024, at 2024-06-30$5.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-14, accession 0001493152-24-031916.Report this figure10.3Cash and equivalents, Q3 FY2024, at 2024-09-30$10.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001493152-24-043931.Report this figure5.9Cash and equivalents, FY2024, at 2024-12-31$5.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-31, accession 0001493152-26-013850.Report this figure2.9Cash and equivalents, Q1 FY2025, at 2025-03-31$2.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0001641172-25-009572.Report this figure4.7Cash and equivalents, Q2 FY2025, at 2025-06-30$4.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-05, accession 0001493152-25-011598.Report this figure5.3Cash and equivalents, Q3 FY2025, at 2025-09-30$5.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001493152-25-022120.Report this figure8.8Cash and equivalents, FY2025, at 2025-12-31$8.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure4.8Cash and equivalents, Q1 FY2026, at 2026-03-31$4.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0001493152-26-022416.Report this figure6.9Cash and equivalents, Q2 FY2026, at 2026-06-30$6.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure
Current assets$m21.7Current assets, Q3 FY2023, at 2023-09-30$21.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-14, accession 0001493152-23-040803.Report this figure18.2Current assets, FY2023, at 2023-12-31$18.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-27, accession 0001493152-25-008460.Report this figure12.1Current assets, Q1 FY2024, at 2024-03-31$12.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-13, accession 0001493152-24-018795.Report this figure7.6Current assets, Q2 FY2024, at 2024-06-30$7.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001493152-24-031916.Report this figure12.5Current assets, Q3 FY2024, at 2024-09-30$12.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001493152-24-043931.Report this figure8.0Current assets, FY2024, at 2024-12-31$8.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-31, accession 0001493152-26-013850.Report this figure5.1Current assets, Q1 FY2025, at 2025-03-31$5.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0001641172-25-009572.Report this figure6.9Current assets, Q2 FY2025, at 2025-06-30$6.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-05, accession 0001493152-25-011598.Report this figure7.3Current assets, Q3 FY2025, at 2025-09-30$7.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001493152-25-022120.Report this figure10.7Current assets, FY2025, at 2025-12-31$10.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure6.6Current assets, Q1 FY2026, at 2026-03-31$6.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0001493152-26-022416.Report this figure8.7Current assets, Q2 FY2026, at 2026-06-30$8.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure
Total assets$m24.7Total assets, Q3 FY2023, at 2023-09-30$24.7m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-14, accession 0001493152-23-040803.Report this figure21.9Total assets, FY2023, at 2023-12-31$21.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-27, accession 0001493152-25-008460.Report this figure14.3Total assets, Q1 FY2024, at 2024-03-31$14.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-13, accession 0001493152-24-018795.Report this figure9.7Total assets, Q2 FY2024, at 2024-06-30$9.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001493152-24-031916.Report this figure14.4Total assets, Q3 FY2024, at 2024-09-30$14.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001493152-24-043931.Report this figure9.7Total assets, FY2024, at 2024-12-31$9.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-31, accession 0001493152-26-013850.Report this figure6.9Total assets, Q1 FY2025, at 2025-03-31$6.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0001641172-25-009572.Report this figure8.8Total assets, Q2 FY2025, at 2025-06-30$8.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-05, accession 0001493152-25-011598.Report this figure9.0Total assets, Q3 FY2025, at 2025-09-30$9.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001493152-25-022120.Report this figure12.3Total assets, FY2025, at 2025-12-31$12.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure8.0Total assets, Q1 FY2026, at 2026-03-31$8.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0001493152-26-022416.Report this figure15.0Total assets, Q2 FY2026, at 2026-06-30$15.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure
Current liabilities$m5.3Current liabilities, Q3 FY2023, at 2023-09-30$5.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-14, accession 0001493152-23-040803.Report this figure7.4Current liabilities, FY2023, at 2023-12-31$7.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-27, accession 0001493152-25-008460.Report this figure4.8Current liabilities, Q1 FY2024, at 2024-03-31$4.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-13, accession 0001493152-24-018795.Report this figure5.1Current liabilities, Q2 FY2024, at 2024-06-30$5.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001493152-24-031916.Report this figure5.4Current liabilities, Q3 FY2024, at 2024-09-30$5.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001493152-24-043931.Report this figure4.8Current liabilities, FY2024, at 2024-12-31$4.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-31, accession 0001493152-26-013850.Report this figure5.8Current liabilities, Q1 FY2025, at 2025-03-31$5.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0001641172-25-009572.Report this figure5.3Current liabilities, Q2 FY2025, at 2025-06-30$5.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-05, accession 0001493152-25-011598.Report this figure4.2Current liabilities, Q3 FY2025, at 2025-09-30$4.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001493152-25-022120.Report this figure4.6Current liabilities, FY2025, at 2025-12-31$4.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure4.2Current liabilities, Q1 FY2026, at 2026-03-31$4.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0001493152-26-022416.Report this figure4.8Current liabilities, Q2 FY2026, at 2026-06-30$4.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure
Total liabilities$m6.6Total liabilities, Q3 FY2023, at 2023-09-30$6.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-14, accession 0001493152-23-040803.Report this figure8.5Total liabilities, FY2023, at 2023-12-31$8.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-27, accession 0001493152-25-008460.Report this figure5.8Total liabilities, Q1 FY2024, at 2024-03-31$5.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-13, accession 0001493152-24-018795.Report this figure6.0Total liabilities, Q2 FY2024, at 2024-06-30$6.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001493152-24-031916.Report this figure6.2Total liabilities, Q3 FY2024, at 2024-09-30$6.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001493152-24-043931.Report this figure5.5Total liabilities, FY2024, at 2024-12-31$5.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-31, accession 0001493152-26-013850.Report this figure6.4Total liabilities, Q1 FY2025, at 2025-03-31$6.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0001641172-25-009572.Report this figure6.1Total liabilities, Q2 FY2025, at 2025-06-30$6.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-05, accession 0001493152-25-011598.Report this figure4.9Total liabilities, Q3 FY2025, at 2025-09-30$4.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001493152-25-022120.Report this figure5.2Total liabilities, FY2025, at 2025-12-31$5.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure4.7Total liabilities, Q1 FY2026, at 2026-03-31$4.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0001493152-26-022416.Report this figure10.8Total liabilities, Q2 FY2026, at 2026-06-30$10.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m18.1Shareholders' equity, Q3 FY2023, at 2023-09-30$18.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001493152-24-043931.Report this figure13.4Shareholders' equity, FY2023, at 2023-12-31$13.4m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-31, accession 0001493152-26-013850.Report this figure8.5Shareholders' equity, Q1 FY2024, at 2024-03-31$8.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-05, accession 0001493152-25-011598.Report this figure3.7Shareholders' equity, Q2 FY2024, at 2024-06-30$3.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022120.Report this figure8.2Shareholders' equity, Q3 FY2024, at 2024-09-30$8.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022120.Report this figure4.2Shareholders' equity, FY2024, at 2024-12-31$4.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure0.5Shareholders' equity, Q1 FY2025, at 2025-03-31$452.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure2.7Shareholders' equity, Q2 FY2025, at 2025-06-30$2.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure4.1Shareholders' equity, Q3 FY2025, at 2025-09-30$4.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001493152-25-022120.Report this figure7.1Shareholders' equity, FY2025, at 2025-12-31$7.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure3.4Shareholders' equity, Q1 FY2026, at 2026-03-31$3.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure4.2Shareholders' equity, Q2 FY2026, at 2026-06-30$4.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure

Cash flow

Operating cash flow−$3.0m, Q2 FY2026
Capital expenditure$3.6k, Q4 FY2025
Imunon, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(4,473)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$4.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001493152-24-043931. Derived: 9-month figure less the 6-month figure.Report this figure(3,772)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$3.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-27, accession 0001493152-25-008460. Derived: 12-month figure less the 9-month figure.Report this figure(5,874)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$5.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0001641172-25-009572.Report this figure(4,505)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$4.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-05, accession 0001493152-25-011598. Derived: 6-month figure less the 3-month figure.Report this figure(4,055)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$4.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001493152-25-022120. Derived: 9-month figure less the 6-month figure.Report this figure(4,421)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$4.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001493152-26-013850. Derived: 12-month figure less the 9-month figure.Report this figure(2,847)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$2.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001493152-26-022416.Report this figure(2,951)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$3.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001493152-26-036991. Derived: 6-month figure less the 3-month figure.Report this figure(4,441)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$4.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001493152-25-022120. Derived: 9-month figure less the 6-month figure.Report this figure(3,657)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$3.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-31, accession 0001493152-26-013850. Derived: 12-month figure less the 9-month figure.Report this figure(3,985)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0001493152-26-022416.Report this figure(3,025)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$3.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001493152-26-036991. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k240Capital expenditure, Q3 FY2023, three months to 2023-09-30$240.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0001493152-24-043931. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-27, accession 0001493152-25-008460. Derived: 12-month figure less the 9-month figure.Report this figure11.8Capital expenditure, Q1 FY2024, three months to 2024-03-31$11.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-12, accession 0001641172-25-009572.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-05, accession 0001493152-25-011598. Derived: 6-month figure less the 3-month figure.Report this figure2.9Capital expenditure, Q3 FY2024, three months to 2024-09-30$2.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001493152-25-022120. Derived: 9-month figure less the 6-month figure.Report this figure14.9Capital expenditure, Q4 FY2024, three months to 2024-12-31$14.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001493152-26-013850. Derived: 12-month figure less the 9-month figure.Report this figure260Capital expenditure, Q1 FY2025, three months to 2025-03-31$259.7k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0001493152-26-022416.Report this figure17.3Capital expenditure, Q2 FY2025, three months to 2025-06-30$17.3k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001493152-26-036991. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001493152-25-022120. Derived: 9-month figure less the 6-month figure.Report this figure3.6Capital expenditure, Q4 FY2025, three months to 2025-12-31$3.6k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-31, accession 0001493152-26-013850. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported

Shares

Diluted shares (weighted)5.23m, Q2 FY2026
Imunon, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)k shares7,099Diluted shares (weighted), Q3 FY2022, three months to 2022-09-307,098,741 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-14, accession 0001493152-23-040803.Report this figure8,281Diluted shares (weighted), Q1 FY2023, three months to 2023-03-318,281,483 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-13, accession 0001493152-24-018795.Report this figure9,137Diluted shares (weighted), Q2 FY2023, three months to 2023-06-309,136,573 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0001493152-24-031916.Report this figure9,377Diluted shares (weighted), Q3 FY2023, three months to 2023-09-309,376,872 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001493152-24-043931.Report this figure9,400Diluted shares (weighted), Q1 FY2024, three months to 2024-03-319,399,831 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0001641172-25-009572.Report this figure627Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30626,726 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-05, accession 0001493152-25-011598.Report this figure1,290Diluted shares (weighted), Q3 FY2024, three months to 2024-09-301,289,823 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001493152-25-022120.Report this figure1,301Diluted shares (weighted), Q1 FY2025, three months to 2025-03-311,300,944 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001493152-26-022416.Report this figure1,277Diluted shares (weighted), Q2 FY2025, three months to 2025-06-301,277,217 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure2,944Diluted shares (weighted), Q3 FY2025, three months to 2025-09-302,943,655 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001493152-25-022120.Report this figure5,029Diluted shares (weighted), Q1 FY2026, three months to 2026-03-315,028,764 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0001493152-26-022416.Report this figure5,233Diluted shares (weighted), Q2 FY2026, three months to 2026-06-305,232,625 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure

Shares outstanding: 5.61mShares outstanding, period not labelled, at 2026-08-105,611,403 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-11, accession 0001493152-26-036991.Report this figure at Aug 10, 2026, from the cover of the 10-Q filed Aug 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. Listed shows no prices and gives no investment advice.